Chelsea Trengrove

Chelsea Trengrove, PhD, currently serves as the CEO and Cofounder of Neoclease, a company dedicated to developing gene-specific nucleases as therapeutics through a generative AI platform. In addition, Chelsea provides strategic advice at Trengrove Consulting LLC and serves on the Advisory Board of Sail For Epilepsy, which focuses on inspiring individuals with epilepsy and promoting awareness. Previous roles include leading strategic partnerships at Regeneron and managing business development at Empatica, where Chelsea facilitated the integration of wearable technology into clinical research. Chelsea's earlier career includes project management positions at Boston Technology Research Corp and a research assistantship at the University of Colorado, supported by a PhD in Neuroscience from Boston University School of Medicine and a BA in Biochemistry and Psychology from the University of Colorado Boulder.